• David A. Katz, Sparrow Pharmaceuticals

    Founder & CSO

    “A great partnership between Sponsor and CRO is the foundation of a highly effective drug development team. FGK impressed us with their open communication, professionalism, and commitment to the project from the start. The FGK team’s expertise across multiple functions has contributed substantially to our success. We look forward to continuing our strong collaboration.”